Achieve Life Sciences, Inc.
ACHV
$4.62
-$0.16-3.35%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
12/5/2025
-
MarketBeat
12/5/2025
-
Tickeron - Technical Analysis
11/26/2025
-
MarketBeat
11/26/2025
-
MarketBeat
11/25/2025
-
GuruFocus
11/25/2025
-
Ticker Report
11/25/2025
-
Insider Monkey
11/25/2025
-
Yahoo! Finance: News
11/25/2025
-
The Fly
11/22/2025
-
MarketBeat
Achieve Life Sciences (ACHV, $3.96) price moved above its 50-day Moving Average on November 21, 2025
11/22/2025
-
Tickeron - Stocks
Achieve Life Sciences (ACHV, $3.88) price may climb as it broke lower Bollinger Band on Nov 20, 2025
11/21/2025
-
Tickeron - Stocks
11/21/2025
-
Tickeron - Stocks
11/13/2025
-
MarketBeat
11/12/2025
-
MarketBeat
Achieve Life Sciences (ACHV, $4.45) price may climb as it broke lower Bollinger Band on Nov 10, 2025
11/11/2025
-
Tickeron - Stocks
11/10/2025
-
MarketBeat
11/8/2025
-
MarketBeat
11/7/2025
-
Ticker Report
11/7/2025
-
TipRanks Financial Blog
11/6/2025
-
GuruFocus
11/6/2025
-
SeekingAlpha.com: All News
11/6/2025
-
SeekingAlpha
11/6/2025
-
Seeking Alpha: Transcripts
11/6/2025
-
GuruFocus
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, November 6, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Mar 9 and 13 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
604 210 2217
Address
22722 29th Dr. SE
Bothell, WA 98021
Bothell, WA 98021
Country
Year Founded
--
Business Description
Sector
Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The...
more